In Phase 2 and early Phase 3 trials, the most common side effects were gastrointestinal, including nausea, diarrhea, vomiting, and constipation, which were generally mild-to-moderate and dose-dependent

Key risk factors include: Rapid weight loss: Losing weight quickly significantly increases gallstone risk Female sex: Women are two to three times more likely to develop gallstones than men Age over 40 years: Gallstone prevalence increases with age Obesity: Higher baseline BMI correlates with increased risk Previous history of gallstones: Prior biliary disease predicts recurrence Family history: Genetic factors contribute to gallstone susceptibility Certain ethnicities: Native American and Hispanic populations have higher baseline rates Estrogen exposure: Oral contraceptives, hormone replacement therapy, and multiple pregnancies Diabetes and dyslipidemia: Metabolic conditions affecting bile composition Prolonged fasting or TPN use: Reduces gallbladder contraction Patients should be educated about warning signs that may indicate gallstone complications
Eroglu, N., et al., Therapeutic effect of N-acetylcysteine on chemotherapy-induced liver injury
GLP-1s are a major topic of conversation right now, said Thomas Collins-Pallett, MD, of Family Medicine Mowry Family Practice at Washington Health
(5) Receive your medication your compounded prescription is shipped via UPS 2-Day Air
8 An amorphous polar terminal could be implemented for practical applications, such as increasing the odds of contact between ligands and receptors under flowing conditions